%0 Journal Article
%T Gastrointestinal Cancer Therapy and Cardiotoxicity.
%A Leiva O
%A Zarif TE
%A Alvarez-Cardona J
%J Curr Treat Options Oncol
%V 0
%N 0
%D 2024 Aug 5
%M 39102169
%F 5.08
%R 10.1007/s11864-024-01236-x
%X <B>UNASSIGNED: </B>Gastrointestinal cancers are a heterogenous group of cancers that share common risk factors with cardiovascular disease. Therapy for gastrointestinal cancers have improved cancer-specific outcomes at the cost of cardiotoxicity. The most common cardiotoxic therapies utilized in gastrointestinal cancers include conventional chemotherapy (including fluoropyrimidines and anthracyclines), targeted therapies including anti-vascular endothelial growth factor (VEGF) therapy and tyrosine kinase inhibitors (TKI), and immunotherapy. It is important for clinicians managing patients with gastrointestinal cancers to be aware of potential cardiotoxicity associated with these agents.